On-demand Anakinra for Colchicine-resistant FMF Attacks
Recruiting Phase 3 NCT06336733
Study Description
Evaluating the Effectiveness of On-demand Anakinra Treatment for Painful Attacks in Patients with Colchicine-resistant Familial Mediterranean Fever (FMF)
Study Details
- Registry ID:
- NCT06336733
- Conditions:
- FMF
- Phase:
- Phase 3
- Target Enrollment:
- 50 participants
- Start Date:
- Age Range:
- 6–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Service de Médecine interne Hopital Tenon
Paris, France
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.